ShortageWatch

Liraglutide Injection shortage

Currently in Shortage

Liraglutide Injection is currently listed as Currently in Shortage in the FDA Drug Shortage Database. Reported reason: Delay in shipping of the drug.

Therapeutic category
Endocrinology/Metabolism
Dosage form
Injection
Routes
SUBCUTANEOUS
Last updated
04/01/2026

Strength variants

  • Not specified

Need sourcing help for Liraglutide Injection?

Get connected with licensed distributors and 503B compounders that can fulfill orders during active shortages. Verified suppliers, no spam.

Connect with a sourcing partner

Manufacturers reporting shortage

Reason for shortage

Delay in shipping of the drug

Availability: Limited Availability

ad slot 300x250

Related shortages in Endocrinology/Metabolism

Dextrose Monohydrate 10% Injection

Currently in Shortage
Category
Endocrinology/Metabolism
Reason
Not specified
Updated
04/07/2026

Dextrose Monohydrate 5% Injection

Currently in Shortage
Category
Endocrinology/Metabolism
Reason
Not specified
Updated
04/07/2026

Dextrose Monohydrate 5% Injection

Currently in Shortage
Category
Endocrinology/Metabolism
Reason
Not specified
Updated
04/07/2026

Dextrose Monohydrate 5% Injection

Currently in Shortage
Category
Endocrinology/Metabolism
Reason
Not specified
Updated
04/07/2026

Dextrose Monohydrate 5% Injection

Currently in Shortage
Category
Endocrinology/Metabolism
Reason
Not specified
Updated
04/07/2026

Dextrose Monohydrate 10% Injection

Currently in Shortage
Category
Endocrinology/Metabolism
Reason
Not specified
Updated
04/07/2026

This information is not medical advice. Consult your pharmacist. Data is sourced from the FDA Drug Shortage Database and may not reflect real-time inventory at your facility. ShortageWatch is independent and not affiliated with the FDA.